Ethnopharmacological relevance: The stem bark of Garcinia livingstonei is used traditionally as a skin lightening agent.
1.

Introduction
Garcinia livingstonei T. Anderson (syn. G. angolensis Vesque)(Clusiaceae) is found throughout tropical Africa, where it occurs as a distinctive small to medium sized (2-10 m) evergreen tree in low altitude riverine fringes and open woodlands (Palgrave, 2002) . It is known variously in South Africa as the African or Lowveld Mangosteen, and umPhimbi, isiHlumanye or uGobandlovu (isiZulu) (Pooley, 1993; Hutchings et al., 1996) . The wood is used as a general purpose timber, while the flesh of the pinkish orange fruit is edible, with a refreshing acid-sweet taste, and can also be fermented to prepare a pleasant alcoholic beverage (Palgrave, 2002) .
The powdered root is used as an aphrodisiac in the treatment of impotence (Arnold and Gulumian, 1984) , for abdominal pains during pregnancy (Samuelsson et al., 1992) , and as an aid in childbirth (Yu, 1982) , while steam from a decoction of the dried leaves is used to treat watering eyes (Arnold and Gulumian, 1984) . Coughs, fevers and parasitic diseases are treated with infusions of the fruits and stems (Iwu, 1993) .
Previous investigations of this species have resulted in the isolation of a variety of bioactive oxygenated aromatic compounds. A series of novel prenylated xanthones was isolated from
Garcinia livingstonei which showed fungiostatic activity against Cladosporium cucumerinum comparable to that of miconazole, and inhibited SW 480 human colon carcinoma cell growth at levels similar to that of 5-fluorouracil (Sordat-Diserens et al., 1992a) . Sordat-Diserens et al. (1992b) isolated the xanthone dimer garcilivin A, which has since been shown to display trypanosomal activity against T. brucei brucei (Mbwambo et al., 2006) . Bioassay-guided fractionation of the fruit has yielded the HIV-inhibitory tetraprenylated benzophenone guttiferone A (3) (Gustafson et al., 1992) , and the biflavanoid ent-naringeninyl- which is moderately active against a Ghanaian CQS strain of P. falciparum (Mbwambo et al., 2006) . Several tree species are used traditionally on the eastern seaboard of South Africa for the treatment of skin diseases and cosmetic purposes, such as for skin lightening, often under the Xhosa and Zulu name umemezi (Earle, 1976; Khan, 1996; Cocks & Dold, 2004; Momtaz et al., 2008) . Although a highly valued ethnomedicinal species (Hutchings et al., 1996) , dermatological uses for Garcinia livingstonei have not earlier been documented either locally, or elsewhere in its extensive tropical African range. Only recently has its application in skin treatment been reported through a personal communication to one of us (NCD) in her capacity as a dermatologist. Clinical observations (Dlova, 2002, unpublished results) have revealed that a water slurry of the powdered stem bark is an effective facial sunscreen and/or skin lightener. A literature search indicated that other Garcinia species such as Garcinia indica Choisy (Jain & DeFilipps, 1991) are used to treat skin diseases, with two taxa, the African Garcinia kola Heckel and the Asian G. subelliptica Merr. reported to yield tyrosinase inhibitors, from leaves and fruit respectively (Masuda et al., 2005; Okunji et al., 2007) .
As no previous studies have focused on this aspect of the use of G. livingstonei, the current work was carried out with the aim of isolating compounds for screening for possible application in skinlightening preparations.
Disorders of hyperpigmentation are seen in all skin types; however, they are encountered more frequently in skin of color (Kanthraj, 2010) . While no single therapy has been shown to be superior or to be of benefit to all patients, sometimes combination therapy is recommended to maximize the management of complex cases (Sheth & Pandya, 2011) . The main goal of treatment is to decrease the hyperpigmentation with minimal side effects. A range of topical agents are available to treat hyperpigmentation and act at different levels of the melanogenesis pathway (Kanthraj, 2010; Sheth & Pandya, 2011) . The most common synthetic pharmacologic agents used are hydroquinone, corticosteroids, and mercurials (Olumide et al., 2008) . The long-term use of these products may cause undesirable cutaneous or systemic side effects (Findlay et al., 1975; Findlay & de Beer, 1980; Olumide et al., 2008) .
p-Hydroquinone (1,4-dihydroxybenzene) was one of the earliest products used for the treatment of hyperpigmentation and remains the standard against which other treatments for hyperpigmentation are measured. (Draelos, 2007; Sheth & Pandya, 2011) . However, its use has been associated with various side effects, which include irritant contact dermatitis and exogenous ochronosis (Findlay & de Beer, 1980; Hardwick et al., 1989; Olumide et al., 2008) . In 1975, Findlay and co-workers reported ochronosis amongst black South African women after prolonged use of skin lightening creams containing p-hydroquinone, which inhibits tyrosinase and prevents the conversion of tyrosine to dihydroxyphenylalanine, a precursor of melanin. Tyrosinase is, accordingly, a potential target in the search for a medically acceptable skin lightening agent from natural sources. This subject has been the focus of a recent review (Smit et al., 2009) .
Given the problems related to hydroquinone use, there exists a need for the identification of novel agents that can be used as skin lightening products, either for cosmetic or clinical use. In this work we examine the properties of compounds isolated from Garcinia livingstonei, measuring both their ability to both alter melanin levels in human melanoma cells, and their relative cytotoxicity.
2.
Experimental section 
Plant material
Stembark of
Isolation of Compounds
The stem bark was air-dried at room temperature and milled, while the fresh fruits were first peeled and the nut-like kernels separated from the surrounding fruit flesh. The dry powdered stem bark (0.65 kg) was successively extracted with dichloromethane, ethyl acetate and methanol for twentyfour hours each, using a Soxhlet apparatus, and the solvents concentrated in vacuo to yield 14.6, 18.7 and 62.2 g of extract, respectively. 1 H NMR and tlc analysis showed that the ethyl acetate and methanol extracts of the stem bark were very similar, and they were combined. Fresh seed kernels (1.2 kg), obtained as described above, were successively extracted in similar fashion with hexane, dichloromethane, ethyl acetate and methanol, yielding 38.9, 2.2, 6.4 and 50.0 g of extract,
respectively. The fresh fruit peel (1 kg wet mass) was soaked in methanol overnight, filtered, and the filtrate concentrated in vacuo to give a suspension, which was extracted with ethyl acetate and concentrated in vacuo, yielding 18.8 g of extract.
Repeated separation by gravity column normal phase (Merck 9385 Si gel) and size exclusion (Sephadex LH-20) chromatography, and semi-preparative scale tlc (Merck 05554 aluminium-backed tlc plates) was undertaken using hexane:dichloromethane:ethyl acetate:acetone:methanol solvent mixtures. The dichloromethane extract of the stem bark yielded betulin, (2.5 g), betulin aldehyde (5 mg), lupeol (5 mg), lupenone (5 mg), euphol (50 mg) and stigmasterol (120 mg). The combined ethyl acetate/methanol extract of the stem bark yielded morelloflavone (1) (20 mg) and morelloflavone-7"-sulphate (2) (20 mg). Guttiferone A (3) (5 mg) was isolated from the fruit peel extract. The hexane extract of the fruit kernels yielded sargaol (4) (50 mg) and isojacareubin (5) (5 mg) and 6-deoxyisojacareubin (6) (5 mg) were isolated from the dichloromethane extract.
Identification of Compounds isolated.
NMR anaylsis was performed on a Bruker 400 MHz NMR spectrophotometer and spectra were determined in CDCl 3 or CD 3 OD. HRMS were recorded on a Finnigan MAT 95 XP high resolution Double Focussing MS at the University of Surrey. Structures of compounds isolated were confirmed by comparison of NMR and MS data against literature values as referenced in Section 3.
In-vitro screening of compounds isolated
A human granular fibroblast cell line derived from malignant melanoma was used in all in vitro assays (MeWo; ECACC No: 93082609) and was purchased from ECACC (Porton Down, UK). Cells were grown in EMEM supplemented with 2mM glutamine, 1% non-essential amino acids, 10%
foetal bovine serum and 100U/ml penicillin, 100 µg/ml streptomycin. All cell culture medium and supplements were purchased from Invitrogen (Paisley, UK). MeWo cells were seeded into 96-well plates (Nunc International, Leicestershire, UK) at a concentration of 10,000 cells/well and incubated at 37 °C for 48 hrs in a humidified container for attachment. Chemicals/crude extracts or vehicle (0.1 % DMSO) was then added to the wells at the indicated concentrations and cells incubated for a further forty-eight hours. Following exposure, medium was collected and cytotoxicity determined by LDH-leakage using the cytotoxicity detection kit (Roche, Lewes, Sussex, UK), as per the manufacturer's instructions. For evaluation of melanin content, cells were washed with PBS, lysed with 1N NaOH and centrifuged to remove cellular debris. The melanin content of the supernatant was then determined by optical density at 405 nm (Takiwaki et al., 2004) .
Results and Discussion
Twelve known compounds, morelloflavone (1) (Li et al., 2002) , morelloflavone-7"-sulphate (2) (Li et al., 2002) , guttiferone A (3) (Gustafson et al., 1992) , sargaol (2-geranyl-6-hydroxy-2,8-dimethylchromene) (4) (Numuta et al., 1992; Voutquenne et al., 1999) , isojacareubin (5) (Helesbeux et al., 2004) , 6-deoxyisojacareubin (6) (Ishiguro et al., 1993) and the common triterpenoids, betulin, betulin aldehyde, lupeol, lupenone, euphol and stigmasterol were isolated in this investigation The structures of the isolated compounds were established using NMR spectroscopy and mass spectrometry and by comparison against literature data as referenced above.
In addition to its HIV-inhibitory activity (Gustafson et al., 1992) , guttiferone A (3) has also been shown to be a potent inhibitor of cholinesterase (Lenta et al., 2007) and glutathione transferase enzymes (Muleya et al., 2008) , as well as exhibiting antioxidant (Ngouela et al., 2006) , leishmanicidal (Lenta et al., 2007) , antiplasmodial (Ngouela et al., 2006) , trypanocidal (Abe et al., 2004) , and cytotoxic (Williams et al., 2003) effects. The activity of morelloflavone (1) as an antiinflammatory (Gil et al., 1997; Castardo et al., 2008) and antioxidant (Sanz et al., 1994; Deachathai et al., 2005; Hutadilok-Towatana et al., 2007) are well-documented; it has also been found to be a potent tyrosinase inhibitor (Masuda et al., 2005) , anti-HIV-1 (Lin et al., 1997) , and anti-bacterial (Verdi et al., 2004) agent, and to have antimalarial (Ngouamegne et al., 2008) and analgesic (Luzzi et al., 1997) properties. Isojacareubin (5) is known for its activity as an anticoagulant (Wu et al., 1998) , and 6-deoxyisojacareubin (6) for its antifungal (Morel et al., 2002) and antibacterial (Kuete et al., 2007) properties, while sargaol (4) shows marked activity as an antioxidant (Nahas et al., 2007) .
Morelloflavone (1), morelloflavone-7"-sulphate (2), guttiferone A (3), and sargaol (4) together with the ethyl acetate and methanol extracts of G. livingstonei stem bark (crude extracts 39b and 39c respectively), and the fruit peel extract, were selected for further in vitro analysis. MeWo cells, a human malignant melanoma cell line, were selected to investigate the action of these compounds and extracts in vitro, both in terms of impact on melanin levels and overall cytotoxicity. The melanin content of the melanocytes was determined after dosing these cells with known concentrations of the test extracts/compounds, whereas the cytotoxicity assay was based on the measurement of lactate dehydrogenase (LDH) released from the cytosol of damaged cells into the culture medium: Full details of the procedures used are given in the Experimental section.
Prior to examining the derived compounds and extracts, the response of MeWo cells to the classical pro-oxidant and skin-lightening agent hydroquinone was examined. As can be seen from figure 2, hydroquinone was able to elicit a dose-dependent decrease in melanin content of the cells, with an EC 50 = 87±1.3 µM. This effect on melanin content was accompanied by dose-dependent cytotoxicity, with an IC 50 = 45±5.4 µM.
Following characterization of the response of MeWo cells to hydroquinone, we next examined the effect of the 25 µM for pure chemicals and 100 mg/mL for crude extracts on both melanin content and cytotoxicity (Figure 3 ). The fruit peel extract was extremely cytotoxic, leading to complete cell death within 48 hours and compromising the LDH readings. In addition, the crude extracts 39b and 39c were both darkly coloured and their melanin readings were thus also compromised; these results will not be discussed further. As previously observed by Williams and colleagues, guttiferone A was shown to be cytotoxic, with 25 µM causing approximately 80% cell death, a value that is consistent with the reported IC 50 value of approximately 1 µM (Williams et al. 2003) . This was the most cytotoxic pure chemical examined, with 25 µM exposures of morrelloflavone, morelloflavone -7"-sulphate and sargaol only causing between 10 -20 % cell death (Figure 3a) .
In addition, all compounds were able to decrease the melanin content of the cells (Figure 3b ), although to differing extents. Again, guttiferone A produced the largest decrease, but this interesting activity was offset by the large cytotoxic effect observed at the same dose. Morelloflavone, morelloflavone -7"-sulphate and sargaol all caused significant decreases in melanin content (approximately 60 % of control; Figure 3 ), while causing less than 20 % cell death at 25 µM.
Accordingly, these compounds were selected for a more complete concentration-response examination. Figure 4 shows concentration-response curves for each compound (1 µM to 100 µM), with both cytotoxicity (LDH) and melanin content measured. Morelloflavone, morelloflavone-7"-sulphate and sargaol all elicited a dose-dependent effect on cytotoxicity and melanin content ( Figure   4a , b, c, respectively). All three compounds elicited a concentration-dependent decrease in melanin content and cytotoxicity in MeWo cells, with morelloflavone-7"-sulphate having the most promising profile. Figure 4b shows a clear separation of the curves for cytotoxicity (IC 50 = 41.8±2.5 µM) and melanin content (EC 50 = 8.6±1.3 µM), suggesting that this compound has the most favourable balance of maximal pharmacological effect with minimal toxicological liability. It should be noted, however, that of the three compounds tested morelloflavone-7"-sulphate also elicits the smallest absolute change in melanin content, being 74 % of control, compared to 13 % for sargaol; the current dose range was insufficient to determine a robust maximal effect for morelloflavone, but it is expected to be in excess of 60 %.
Conclusion
Morelloflavone (1), morelloflavone-7"-sulphate (2), guttiferone A (3), and sargaol (4) are all more effective in reducing melanin content of MeWo human melanoma cells than hydroquinone. In addition, morelloflavone , morelloflavone-7"-sulphate , and sargaol are less cytotoxic. Although morelloflavone, isolated from Japanese material of Garcinia subelliptica has previously been shown to possess potent tyrosinase inhibitory activity (Masuda et al., 2005) , the current investigation revealed that morelloflavone-7"-sulphate 7 possessed the best separation between reduction in melanin and induction of cell death.
In conclusion, preliminary results show that morelloflavone, morelloflavone-7"-sulphate and sargaol are highly effective melanin production inhibitors. When tested in the human melanoma cell line MeWo, they inhibit melanogenesis to a greater extent than hydroquinone, whilst causing less cytotoxicity. As such, these compounds represent good candidates for further development of novel skin lightening agents to be used in the cosmetic and clinical arenas. 
